1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Generics in Scandinavia

Generics in Scandinavia

  • January 2017
  • -
  • MarketLine
  • -
  • 32 pages

Summary

Table of Contents

Search Inside

Summary
Generics in Scandinavia industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Scandinavia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Scandinavia
- Leading company profiles reveal details of key generics market players' global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Scandinavia generics market with five year forecasts by both value and volume

Synopsis
Essential resource for top-line data and analysis covering the Scandinavia generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons To Buy
- What was the size of the Scandinavia generics market by value in 2016?
- What will be the size of the Scandinavia generics market in 2021?
- What factors are affecting the strength of competition in the Scandinavia generics market?
- How has the market performed over the last five years?
- How large is Scandinavia's generics market in relation to its regional counterparts?

Key Findings
For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

The Scandinavian generics market is expected to generate total revenues of $2.5bn in 2016, representing a compound annual growth rate (CAGR) of 4.6% between 2012 and 2016.

Market consumption volume is forecast to decline with a compound annual rate of change (CARC) of -2.8% between 2012 and 2016, to reach a total of 47.8% of total pharma volume in 2016.

Denmark has some of the lowest prices on generics in Europe; they are around 86% lower than Norwegian prices and 12% lower than Swedish prices. Generic drugs represent a saving of DKK1bn compared to Norway and DKK750m compared to Sweden.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.